Relay Therapeutics (RLAY) EV/EBITDA: History & Chart

Relay Therapeutics, Inc.(RLAY)

Biotechnology · Cambridge, MA

$18.23-1.16 (-5.98%)

Delayed quote: Oct 6, 2026, 1:50 PM EDT

About Relay Therapeutics, Inc.

Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced or metastatic solid tumors exhibiting FGFR2 alterations; RLY-2608, a leading program targeting mutant phosphoinositide 3 kinase alpha (PI3Ka); and RLY-1971, another oral small molecule, an inhibitor of SHP2 (protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2), currently in Phase 1 trials for individuals with advanced solid tumors. Relay Therapeutics has established strategic partnerships, including a collaboration with D. E. Shaw Research, LLC, which utilizes computational modeling to analyze protein motion for the identification and development of therapeutic compounds. Furthermore, an agreement with Genentech, Inc. supports the development and commercialization of RLY-1971. Founded in 2015 as Allostery, Inc., the company rebranded to Relay Therapeutics, Inc. in December of that year and maintains its headquarters in Cambridge, Massachusetts.

Cambridge, MA

202 employees

www.relaytx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Sanjiv K. Patel

View full financials

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Relay Therapeutics, Inc. (RLAY)	$4.00B	N/A	N/A	N/A	N/A
AbCellera Biologics Inc. (ABCL)vs ›	$4.02B	N/A	8.40x	13.30x	13.30x
ICU Medical, Inc. (ICUI)vs ›	$3.95B	13.54x	16.01x	14.76x	19.10x
LivaNova PLC (LIVN)vs ›	$4.14B	16.28x	14.83x	60.35x	57.23x
Regencell Bioscience Holdings Limited (RGC)vs ›	$3.79B	N/A	N/A	N/A	N/A
Edgewise Therapeutics, Inc. (EWTX)vs ›	$4.28B	N/A	N/A	N/A	N/A
Adaptive Biotechnologies Corporation (ADPT)vs ›	$4.39B	N/A	N/A	N/A	N/A
Indivior Pharmaceuticals Inc (INDV)vs ›	$4.41B	8.81x	11.30x	25.94x	24.40x
Heartflow, Inc. Common Stock (HTFL)vs ›	$4.43B	N/A	N/A	N/A	N/A
iRhythm Technologies, Inc. (IRTC)vs ›	$3.55B	287.96x	665.65x	665.65x	665.65x

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

Relay Therapeutics, Inc. (RLAY)

$4.00B

N/A

AbCellera Biologics Inc. (ABCL)vs ›

$4.02B

N/A

8.40x

13.30x